Recce Pharmaceuticals Ltd. announced the formation of a Clinical Advisory Committee to assist in the Board's growing clinical considerations under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS). The new Clinical Advisory Committee will be chaired by Dr. David Bowers, Spinal Injury Physician at Royal North Shore and other University Hospitals in Sydney.